2929
Pharma Foods International Co., Ltd.
株式会社ファーマフーズ
Foods
Pharma Foods International Co., Ltd. engages in the development and sale of functional food ingredients in Japan. It also focuses on biomedical drug discovery of antibody and peptide drugs targeting diseases, including autoimmune, cancer, and inflammatory. The company was founded in 1997 and is headquartered in Kyoto, Japan.
Read more
← Companies
Overview
Filings & Signals
Ownership
Financials
▾ Collapse Charts
Income Statement
Balance Sheet
Cash Flow
Ratios & Per Share
Metric
FY 2025
EDINET ↗
FY 2024
EDINET ↗
FY 2023
EDINET ↗
FY 2022
EDINET ↗
FY 2021
EDINET ↗
Net Sales
¥65.3B
¥62.1B
¥68.6B
¥60.2B
¥46.8B
Cost of Sales
¥12.7B
¥13.4B
¥13.3B
¥12.1B
¥7.0B
Gross Profit
¥52.6B
¥48.8B
¥55.3B
¥48.1B
¥39.7B
SG&A
¥50.2B
¥43.6B
¥51.7B
¥47.0B
¥34.1B
Operating Income
¥2.4B
¥5.1B
¥3.6B
¥1.1B
¥5.7B
Non-Operating Income
¥472M
¥285M
¥169M
¥228M
¥114M
Dividend Income
¥32M
¥28M
¥26M
¥36M
¥3M
Interest Income
¥6M
¥1M
¥1M
¥2M
¥3M
Non-Operating Expenses
¥286M
¥150M
¥239M
¥43M
¥20M
Interest Expense
¥91M
¥62M
¥48M
¥26M
¥12M
Ordinary Income
¥2.6B
¥5.2B
¥3.5B
¥1.3B
¥5.8B
Pre-tax Income
¥2.4B
¥5.0B
¥3.5B
¥1.4B
¥5.8B
Income Taxes
¥2.1B
¥1.8B
¥462M
¥1.8B
¥1.9B
Current Tax
¥2.3B
¥1.8B
¥922M
¥1.4B
¥2.0B
Deferred Tax
¥-190M
¥42M
¥-460M
¥397M
¥-63M
Net Income (owners)
¥368M
¥3.2B
¥3.1B
¥-374M
¥3.8B
Minority Interest
—
—
¥0M
—
—
Comprehensive Income
¥-3M
¥3.4B
¥3.4B
¥-336M
¥3.8B
EBITDA
¥3.2B
¥6.0B
¥4.2B
¥1.6B
¥5.9B
Goodwill Amort. (J-GAAP)
¥53M
¥99M
¥72M
¥51M
¥43M
EPS
¥12.83
¥112.71
¥106.70
¥-12.89
¥132.21
Shares Outstanding
28.9M
28.1M
28.8M
29.0M
29.1M
Shares Issued (total)
29.1M
29.1M
29.1M
29.1M
29.1M
Treasury Shares
0.2M
1.0M
0.2M
0.1M
—
Metric
FY 2025
EDINET ↗
FY 2024
EDINET ↗
FY 2023
EDINET ↗
FY 2022
EDINET ↗
FY 2021
EDINET ↗
Total Assets
¥32.6B
¥36.6B
¥36.2B
¥31.2B
¥20.9B
Current Assets
¥23.9B
¥27.3B
¥27.5B
¥23.5B
¥17.9B
Cash & Deposits
¥9.2B
¥15.7B
¥16.3B
¥8.8B
¥9.8B
Trade Receivables
¥5.0B
¥4.0B
¥4.0B
¥6.7B
—
Non-Current Assets
¥8.8B
¥9.3B
¥8.7B
¥7.6B
¥3.0B
PP&E
¥4.7B
¥4.6B
¥4.4B
¥4.5B
¥1.8B
Goodwill
¥71M
¥124M
¥197M
¥270M
¥140M
Intangible Assets
¥120M
¥177M
¥238M
¥305M
¥185M
Investment Securities
¥2.5B
¥3.0B
¥2.5B
¥1.6B
¥335M
Deferred Tax Assets
¥515M
¥351M
¥395M
—
—
Total Liabilities
¥21.1B
¥25.0B
¥26.6B
¥24.1B
¥12.5B
Current Liabilities
¥20.0B
¥23.2B
¥24.4B
¥22.8B
¥11.0B
Accounts Payable
¥1.9B
¥1.2B
¥937M
¥1.2B
¥846M
ST Debt
¥12.0B
¥15.7B
¥18.4B
¥16.2B
¥3.4B
Taxes Payable
¥1.5B
¥1.4B
¥264M
¥434M
¥2.0B
Non-Current Liabilities
¥1.1B
¥1.8B
¥2.2B
¥1.3B
¥1.5B
Total LT Borrowings
¥671M
¥1.2B
¥1.7B
¥697M
¥1.5B
Pension Obligations
¥378M
¥384M
¥320M
¥427M
¥16M
Total Equity
¥11.5B
¥11.6B
¥9.6B
¥7.1B
¥8.5B
Capital Stock
¥2.0B
¥2.0B
¥2.0B
¥2.0B
¥2.0B
Capital Surplus
¥1.8B
¥1.8B
¥1.8B
¥1.8B
¥1.8B
Retained Earnings
¥7.7B
¥8.4B
¥5.8B
¥3.3B
¥4.6B
Treasury Stock
¥-195M
¥-1.2B
¥-343M
¥-138M
—
AOCI
¥193M
¥566M
¥324M
¥46M
¥8M
Equity (owners)
¥11.4B
¥11.0B
¥9.3B
¥7.0B
¥8.5B
Minority Interests
—
—
—
¥2M
—
Total Interest-Bearing Debt ⓘ
¥12.6B
¥16.9B
¥20.1B
¥16.9B
¥4.9B
Net Cash ⓘ
¥-3.5B
¥-1.2B
¥-3.8B
¥-8.0B
¥4.9B
NCAV ⓘ
¥2.8B
¥2.3B
¥929M
¥-571M
¥5.5B
NCAV/Share
¥96
¥82
¥32
¥-20
¥188
BV/Share
¥393
¥393
¥323
¥242
¥291
Metric
FY 2025
EDINET ↗
FY 2024
EDINET ↗
FY 2023
EDINET ↗
FY 2022
EDINET ↗
FY 2021
EDINET ↗
Operating CF
¥-1.1B
¥5.5B
¥6.1B
¥-6.1B
¥5.9B
Interest Paid
¥-91M
¥-62M
¥-48M
¥-29M
¥-11M
Interest Received
¥38M
¥30M
¥28M
¥39M
¥6M
D&A
¥732M
¥808M
¥474M
¥469M
¥138M
Goodwill Amort.
¥53M
¥99M
¥72M
¥51M
¥43M
Investing CF
¥-950M
¥-1.4B
¥-1.0B
¥-2.5B
¥-442M
CapEx
¥891M
¥841M
¥386M
¥467M
¥154M
Purchase Investments
¥-64M
¥-363M
¥-700M
¥-1.0B
¥-200M
Proceeds from Invest.
¥0M
¥53M
—
—
—
Financing CF
¥-4.5B
¥-4.8B
¥2.3B
¥7.7B
¥1.0B
Dividends Paid
¥-784M
¥-626M
¥-578M
¥-871M
¥-290M
Share Buybacks
¥-175M
¥-999M
¥-300M
¥-299M
—
LT Debt Repaid
¥-760M
¥-1.0B
¥-760M
¥-3.2B
¥-1.2B
Free Cash Flow
¥-2.0B
¥4.6B
¥5.7B
¥-6.5B
¥5.8B
Net Change in Cash
¥-6.5B
¥-739M
¥7.5B
¥-948M
¥6.5B
Metric
FY 2025
EDINET ↗
FY 2024
EDINET ↗
FY 2023
EDINET ↗
FY 2022
EDINET ↗
FY 2021
EDINET ↗
ROE
3.2%
30.2%
36.9%
-4.8%
57.5%
ROA
1.1%
8.8%
9.1%
-1.4%
18.3%
EPS
¥12.83
¥112.71
¥106.70
¥-12.89
¥132.21
DPS
¥25.00
¥25.00
¥22.00
¥20.00
¥25.00
BPS
¥399.95
¥412.71
¥333.88
¥243.65
¥291.25
FCF/Share
¥-69
¥165
¥199
¥-225
¥199
NCAV/Share
¥96
¥82
¥32
¥-20
¥188
Payout Ratio
194.9%
22.2%
20.6%
—
18.9%
Event Timeline
S Shareholder
A Capital Signal
▾ Hide Chart
Large Shareholder Reports 3
Date Activist Stake Event Flag Demands Source
2025-12-05
Nomura Securities Co.,Ltd.
2.56%
-2.85%
change
Passive
—
2025-08-21
Nomura Securities Co.,Ltd.
5.41%
initial_5pct
Passive
—
2024-02-09
KIM MUJO
13.61%
correction
Passive
—
Top 10 Shareholders
Ownership DNA
Cross-Holdings Tracker 4
#
Shareholder
Shares (thou.)
% of Total
1
The Master Trust Bank of Japan, Ltd. (Trust Account)
日本マスタートラスト信託銀行株式会社(信託口)
3,122,700
10.82%
2
金 武祚
2,227,334
7.71%
3
株式会社PFホールディングス
1,480,000
5.13%
4
伊藤忠商事株式会社
1,452,000
5.03%
5
益田 和二行
736,685
2.55%
6
EZAKI GLICO CO.,LTD.
江崎グリコ株式会社
732,000
2.54%
7
金 英一
672,006
2.33%
8
ROHTO PHARMACEUTICAL CO.,LTD.
ロート製薬株式会社
600,000
2.08%
9
金 千尋
509,100
1.76%
10
益田 美玲
453,300
1.57%
Domestic Nominees
10.8%
-0.2% vs 2024
Trust bank custodians — GPIF, pensions, investment trusts
Foreign Custodians
0.0%
+0.0% vs 2024
Sub-custodians for foreign asset managers
Direct / Strategic
30.7%
+4.4% vs 2024
Named entities with disclosed investment intent
Shareholder
Trend
2023
2024
2025
Japan Master Trust Bank
日本マスタートラスト信託銀行
9.20%
8.75%
10.82%
+2.07%
金 武祚
7.54%
7.82%
7.71%
-0.11%
式会社PFホールディングス
5.13%
5.27%
5.13%
-0.14%
伊藤忠商事
NEW ENTRY
—
—
—
5.03%
NEW
益田 和二行
2.42%
2.55%
2.55%
EZAKI GLICO CO.,LTD.
江崎グリコ
2.54%
2.61%
2.54%
-0.07%
金 英一
2.25%
2.36%
2.33%
-0.03%
ROHTO PHARMACEUTICAL CO.,LTD.
ロート製薬
2.08%
2.14%
2.08%
-0.06%
金 千尋
1.76%
1.81%
1.76%
-0.05%
益田 美玲
1.68%
1.72%
1.57%
-0.15%
Japan Custody Bank
日本カストディ銀行
last seen 2024
Exited Top 10
2.13%
2.22%
—
Concentration (HHI)
ⓘ
200
200
256
3 fiscal years · top-10 holders per year · >2,500 HHI = high concentration · entity-resolved
Portfolio Book Value
¥1,174M
-24% since 2023
Holdings
4
Trend
Stable
vs 2023
Held Company
FY2025
¥1,174M total
FY2023
¥1,541M total
Book Val ¥M
Shares
Book Val ¥M
Shares
ROHTO PHARMACEUTICAL CO.,LTD.
ロート製薬株式会社
882
406,000
1,230
406,000
M
SANYO CHEMICAL INDUSTRIES,LTD.
三洋化成工業株式会社
267
67,400
291
67,400
M
EZAKI GLICO CO.,LTD.
江崎グリコ株式会社
23
5,000
18
5,000
M
NH Foods Ltd.
日本ハム株式会社
2
500
2
500
Portfolio total
1,174
1,541
Book value in ¥M · ↓ reduced · ↑ increased vs prior year · M = mutual holding